PHC GARETHA

GARETHA
VIDISHA MADHYA PRADESH - . PHONE NO. - 0

PATIENT NAME : MRS RAMKALI SHAKYA W/O BANTI SHAKYA

AGE/GENDER : 28 Y / Female SHUHID # : H0108044/018293 ORDERED ON : 28-11-2023 05:18 PM

MOBILE : 8815266209 OPD/IPD/ANC # : SAMPLE ON: : 28-11-2023 05:19 PM

ORDER # : 9053 REFERRED BY : REPORTED ON : 30-11-2023 03:13 PM

VISIT TYPE : OPD

Vitamin D
TEST RESULT UNIT REFERENCE
1. >30 Ng/ML : Sufficiency ~ 2. 21-29
VITAMIN D, SERUM 26 ng/ml Ng/ML : Insufficiency - 3. <20 Ng/ML :
Deficiency
NOTES : EXPECTED VALUE
DEFICIENCY (SERIOUSLY DEFICIENT) : < 12 ng/ml
INSUFFICIENCY (DEFICIENT) : 12-30 ng/ml
SUFFICIENCY (ADEQUATELY SUPPLIED) : > 30 ng/ml
INTERPRETATION
Vitamin D is a steroid hormone involved in the intestinal absorption of calcium and the regulation of calcium
homeostasis. There are two different forms of vitamin D, named D3 and D2 which are very similar in structure.
The D2 is a synthetic product, which is predominantly absorbed by fortified food. Physiological vitamin D3
levels result not only from dietary uptake but can also be produced from a cholesterol precursor,
7-dehydrocholesterol, in the skin during sun exposure. In the liver, the vitamin is hydroxylated to 25-hydroxyvitamin D
(25(OH)-vitamin D), the major circulating metabolite of vitamin D. Although 1.25-(OH)2 vitamin D portrays the
biological active form of vitamin D, which is synthesized in the kidney, it is widely accepted that the measurement of
circulating 25(OH)-vitamin D provides better information with respect to patients vitamin D status and allows its use in
diagnosehypovitaminosis(1,2). The concentration of 25(OH)-vitamin D decreases with age and a deficiency is common
among elderly persons. Clinical applications of 25(OH)-vitamin D measurements are the diagnosis and therapy control
of postmenopausal osteoporosis, rickets, osteomalacia, renal osteodystrophy, pregnancy, neonatal hypocalcemia and
hyperparathyroidism.In addition, a prevalence of sub-clinical vitamin D deficiency has been discussed in different
European countries.
TSH
TEST RESULT UNIT REFERENCE
0.35-5.1 mIU/mL - Pregnant : T1 : 0.05-
Thyroid Stimulating Hormones (TSH) 2.3 µIU/mL 4.73 mIU/ML T2 : 0.30-4.79 mIU/ML T3
: 0.50-6.02 mIU/ML
NOTES : The thyroid gland is normally regulated by Thyroid-stimulating hormone (TSH) also called Thyrotropin, which
is secreted by the pituitary. TSH secretion is also influenced by Thyrotropin-releasing hormone (TRH) synthesized
in the Hypothalamus. TSH stimulates the thyroid gland to produce and release .Thyroxine (T4) and Triiodothyronine
(T3) . T4 and T3 are released from the Thyroid into the blood stream, where they are bound to the serum proteins.
Thyroxine-binding prealbumin, Albumin and Thyroxine-binding globulin (TBG). TBG normally accounts for about
75% of the bound hormones. About 0.03% of the total serum T4 and 0.3% of the total serum T3 are free. Only free
T4 and T3 are metabolically active. Hereditary disorders in TBG production, Acute Liver disease and Medications such
as Methadone, Aspirin ,Pregnancy, increased Estrogen level are additional causes of an increased TBG level. Certain
circumstances, including stress, Trauma, Medications, infections and temperature fluctuations, few drugs change the
amount of Thyroid hormone required by the body, causing altered TSH level therefore this report should be read in
conjunction with other clinical findings and investigation.
T3
TEST RESULT UNIT REFERENCE
Total Triiodothyronine T3 1.08 ng/ml 0.8 - 1.9

NOTES :

Page 1 of 4
 PHC GARETHA
GARETHA
VIDISHA MADHYA PRADESH - . PHONE NO. - 0

PATIENT NAME : MRS RAMKALI SHAKYA W/O BANTI SHAKYA

AGE/GENDER : 28 Y / Female SHUHID # : H0108044/018293 ORDERED ON : 28-11-2023 05:18 PM

MOBILE : 8815266209 OPD/IPD/ANC # : SAMPLE ON: : 28-11-2023 05:19 PM

ORDER # : 9053 REFERRED BY : REPORTED ON : 30-11-2023 03:13 PM

VISIT TYPE : OPD

T4
TEST RESULT UNIT REFERENCE
T4 94.3 nmol/L 64.35 - 186.61

NOTES :

Serum Calcium
TEST RESULT UNIT REFERENCE
SERUM CALCIUM 9.1 mg/dl 8.6 - 10.3

NOTES :

Serum Billirubin Direct and Indirect

TEST RESULT UNIT REFERENCE
SERUM BILIRUBIN (TOTAL) 0.65 mg/dl 0.30 - 1.200

SERUM BILIRUBIN (DIRECT) 0.28 Mg/dl 0.0 - 0.30

INDIRECT BILIRUBIN 0.37 mg/dl 0.0 - 0.7

NOTES :

Serum creatinine
TEST RESULT UNIT REFERENCE
CREATININE 0.62 mg/dl 0.60 - 1.30

NOTES :

Alkaline Phosphatase
TEST RESULT UNIT REFERENCE
SERUM ALKALINE PHOSPHATASE 85.23 u/l 70 - 270

NOTES :

Serum Uric Acid

TEST RESULT UNIT REFERENCE
Uric Acid 3.2 mg/dl 2.6 - 7.2

NOTES :

Page 2 of 4
 PHC GARETHA
GARETHA
VIDISHA MADHYA PRADESH - . PHONE NO. - 0

PATIENT NAME : MRS RAMKALI SHAKYA W/O BANTI SHAKYA

AGE/GENDER : 28 Y / Female SHUHID # : H0108044/018293 ORDERED ON : 28-11-2023 05:18 PM

MOBILE : 8815266209 OPD/IPD/ANC # : SAMPLE ON: : 28-11-2023 05:19 PM

ORDER # : 9053 REFERRED BY : REPORTED ON : 30-11-2023 03:13 PM

VISIT TYPE : OPD

SGOT
TEST RESULT UNIT REFERENCE
SGOT 25.78 U/L 5 - 40

NOTES :

Serum Protein Total

TEST RESULT UNIT REFERENCE
TOTAL PROTEIN 7.4 g/dl 6.30 - 8.50

NOTES :

SGPT
TEST RESULT UNIT REFERENCE
SGPT 32.58 U/L 5 - 45

NOTES :

CBC
TEST RESULT UNIT REFERENCE
HEMOGLOBIN 10.6 gm/dl 11.5 - 13.5

TOTAL ERYTHROCYTE COUNT 3.48 10^6/µL 3.8 - 4.8

HCT 33.6 % 40 - 59

MCV 96.7 fL 80 - 96

MCH 30.5 pg 26 - 35

MCHC 31.5 g/dL 29 - 37

R D W-CV 15.0 % 11 - 14

TOTAL LEUCOCYTE COUNT 3.5 10^3/µL 4 - 11

NEUTROPHILS 61.8 % 40 - 75

LYMPHOCYTES 34.2 % 20 - 45

MID 4.0 % -

PLATELET COUNT 22 10^3 / cu.mm 150 - 450

NOTES :

Page 3 of 4
 PHC GARETHA
GARETHA
VIDISHA MADHYA PRADESH - . PHONE NO. - 0

PATIENT NAME : MRS RAMKALI SHAKYA W/O BANTI SHAKYA

AGE/GENDER : 28 Y / Female SHUHID # : H0108044/018293 ORDERED ON : 28-11-2023 05:18 PM

MOBILE : 8815266209 OPD/IPD/ANC # : SAMPLE ON: : 28-11-2023 05:19 PM

ORDER # : 9053 REFERRED BY : REPORTED ON : 30-11-2023 03:13 PM

VISIT TYPE : OPD

POOJA RAJORIYA DR AMIT BHEDIA

PRINTED BY TECHNICIAN BMO
-------------- End of Report ---------------

NOTE: PLEASE CORRELATE WITH CLINICAL CONDITION. DISCLAIMER: THIS REPORT IS ELECTRONICALLY SIGNED.

Page 4 of 4